Intrahepatic bile duct cancer
MONDO:0001487A cancer that involves the intrahepatic bile duct.
Also known as: cancer of intrahepatic bile duct, malignant intrahepatic bile duct neoplasm, malignant neoplasm of intrahepatic bile duct, malignant neoplasm of intrahepatic bile ducts
3105 clinical trials for this condition and its sub-types, 6 tagged with Intrahepatic bile duct cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Intrahepatic bile duct cancer
-
Intrahepatic cholangiocarcinoma 154 trials · 176 incl. sub-types
6 sub-types
- Hilar cholangiocarcinoma 36 trials
- Perihilar intrahepatic cholangiocarcinoma 25 trials
- Cholangiolocellular carcinoma 1 trial
- Mucinous intrahepatic cholangiocarcinoma 0 trials
- Sarcomatous intrahepatic cholangiocarcinoma 0 trials
- Signet ring cell intrahepatic cholangiocarcinoma 0 trials
-
New hope for liver metastases: immune booster combined with targeted chemo
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard chemotherapy delivered directly to the liver can help people with colorectal, bile duct, or adrenal cancer that has spread to the liver. About 70 adults will receive the drug combination along with a s…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New cancer drug YL211 enters first human tests
Disease control Recruiting nowThis early-stage trial tests a new drug called YL211 in 155 people with advanced solid tumors who have no standard treatment options left. The study has three parts: first, finding a safe dose; then, confirming that dose; and finally, testing how well it works. The main goals are…
Phase 1 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New chemo mist targets abdominal cancer with fewer side effects
Disease control Recruiting nowThis early-stage trial tests a technique called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. The goal is to see if this method is safe and reduces side effects for people with biliary tract cancer that has spre…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC